New! Learn more about the all new DeepDyve personalized home page where you can quickly skim your favorite journals all from one place

Drug Metabolism and Disposition Volume 37 Issue 3

2013
- Volume 41
  - Issue 2 (Feb)
  - Issue 1 (Jan)
2012
- Volume 40
2011
- Volume 39
2010
- Volume 38
2009
- Volume 37
2008
- Volume 36
2007
- Volume 35
2006
- Volume 34
2005
- Volume 33
2004
- Volume 32
2003
- Volume 31
2002
- Volume 30
2001
- Volume 29
2000
- Volume 28
1999
- Volume 27
1998
- Volume 26
1997
- Volume 25

Bookmark
More Like This 0vPhsjex8T Preview Only

Effect of CYP2A13 Active Site Mutation N297A on Metabolism of Coumarin and Tobacco-Specific Nitrosamines

Schlicht, Kari E.; Berg, Jeannette Zinggeler; Murphy, Sharon E.

Follow Drug Metabolism and Disposition , Volume 37 (3): 665 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009
Bookmark
More Like This 5mz0ZrXDF0 Preview Only

Hepatic Flavin-Containing Monooxygenase Gene Regulation in Different Mouse Inflammation Models

Zhang, Jun; Chaluvadi, Madhusudana R.; Reddy, Rob; Motika, Meike S.; Richardson, Terrilyn A.; Cashman, John R.; Morgan, Edward T.

Follow Drug Metabolism and Disposition , Volume 37 (3): 462 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009
Bookmark
More Like This WFn1K6xEJh Preview Only

Use of Sandwich-Cultured Human Hepatocytes to Predict Biliary Clearance of Angiotensin II Receptor Blockers and HMG-CoA Reductase Inhibitors

Abe, Koji; Bridges, Arlene S.; Brouwer, Kim L. R.

Follow Drug Metabolism and Disposition , Volume 37 (3): 447 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009
Bookmark
More Like This o3Yk5jfmJi Preview Only

Species Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein Transport

Syvänen, Stina; Lindhe, Örjan; Palner, Mikael; Kornum, Birgitte R.; Rahman, Obaidur; Långström, Bengt; Knudsen, Gitte M.; Hammarlund-Udenaes, Margareta

Follow Drug Metabolism and Disposition , Volume 37 (3): 635 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009
Bookmark
More Like This bbPVU17050 Preview Only

Mechanism-Based Inhibition of Human Cytochrome P450 2B6 by Ticlopidine, Clopidogrel, and the Thiolactone Metabolite of Prasugrel

Nishiya, Yumi; Hagihara, Katsunobu; Ito, Takashi; Tajima, Masami; Miura, Shin-ichi; Kurihara, Atsushi; Farid, Nagy A.; Ikeda, Toshihiko

Follow Drug Metabolism and Disposition , Volume 37 (3): 589 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009
Bookmark
More Like This A6ZvXmg0cN Preview Only

An Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido2,3-dpyrimidin-2-yl-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple Dosing

Tonn, George R.; Wong, Simon G.; Wong, Sylvia C.; Johnson, Michael G.; Ma, Ji; Cho, Robert; Floren, Leslie C.; Kersey, Kathryn; Berry, Karen; Marcus, Andrew P.; Wang, Xuemei; Van Lengerich, Bettina; Medina, Julio C.; Pearson, Paul G.; Wong, Bradley K.

Follow Drug Metabolism and Disposition , Volume 37 (3): 502 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009
Bookmark
More Like This 43KMJcqCaW Preview Only

Decreased Susceptibility of the Cytochrome P450 2B6 Variant K262R to Inhibition by Several Clinically Important Drugs

Talakad, Jyothi C.; Kumar, Santosh; Halpert, James R.

Follow Drug Metabolism and Disposition , Volume 37 (3): 644 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009
Bookmark
More Like This MHQTHjH0Wz Preview Only

SIMDOT-AbMe: Microphysiologically Based Simulation Tool for Quantitative Prediction of Systemic and Local Bioavailability of Targeted Oral Delivery Formulations

Haddish-Berhane, Nahor; Farhadi, Ashkan; Nyquist, Chell; Haghighi, Kamyar; Keshavarzian, Ali

Follow Drug Metabolism and Disposition , Volume 37 (3): 608 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009
Bookmark
More Like This Go6htp8TrK Preview Only

Absorption, Metabolism, and Excretion of 14CVildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Humans

He, Handan; Tran, Phi; Yin, Hequn; Smith, Harold; Batard, Yannick; Wang, Lai; Einolf, Heidi; Gu, Helen; Mangold, James B.; Fischer, Volker; Howard, Dan

Follow Drug Metabolism and Disposition , Volume 37 (3): 536 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009
Bookmark
More Like This fmneXX8QsK Preview Only

Carrier-Mediated Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho2,3-dimidazolium Bromide (YM155 Monobromide), a Novel Small-Molecule Survivin Suppressant, into Human Solid Tumor and Lymphoma Cells

Minematsu, Tsuyoshi; Iwai, Megumi; Sugimoto, Kenji; Shirai, Nobuaki; Nakahara, Takahito; Usui, Takashi; Kamimura, Hidetaka

Follow Drug Metabolism and Disposition , Volume 37 (3): 619 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

Drug Metabolism and Disposition Volume 37 Issue 3

Effect of CYP2A13 Active Site Mutation N297A on Metabolism of Coumarin and Tobacco-Specific Nitrosamines

Schlicht, Kari E.; Berg, Jeannette Zinggeler; Murphy, Sharon E.

Follow Drug Metabolism and Disposition , Volume 37 (3): 665 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

Hepatic Flavin-Containing Monooxygenase Gene Regulation in Different Mouse Inflammation Models

Zhang, Jun; Chaluvadi, Madhusudana R.; Reddy, Rob; Motika, Meike S.; Richardson, Terrilyn A.; Cashman, John R.; Morgan, Edward T.

Follow Drug Metabolism and Disposition , Volume 37 (3): 462 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

Use of Sandwich-Cultured Human Hepatocytes to Predict Biliary Clearance of Angiotensin II Receptor Blockers and HMG-CoA Reductase Inhibitors

Abe, Koji; Bridges, Arlene S.; Brouwer, Kim L. R.

Follow Drug Metabolism and Disposition , Volume 37 (3): 447 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

Species Differences in Blood-Brain Barrier Transport of Three Positron Emission Tomography Radioligands with Emphasis on P-Glycoprotein Transport

Syvänen, Stina; Lindhe, Örjan; Palner, Mikael; Kornum, Birgitte R.; Rahman, Obaidur; Långström, Bengt; Knudsen, Gitte M.; Hammarlund-Udenaes, Margareta

Follow Drug Metabolism and Disposition , Volume 37 (3): 635 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

Mechanism-Based Inhibition of Human Cytochrome P450 2B6 by Ticlopidine, Clopidogrel, and the Thiolactone Metabolite of Prasugrel

Nishiya, Yumi; Hagihara, Katsunobu; Ito, Takashi; Tajima, Masami; Miura, Shin-ichi; Kurihara, Atsushi; Farid, Nagy A.; Ikeda, Toshihiko

Follow Drug Metabolism and Disposition , Volume 37 (3): 589 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

An Inhibitory Metabolite Leads to Dose- and Time-Dependent Pharmacokinetics of (R)-N-{1-3-(4-Ethoxy-phenyl)-4-oxo-3,4-dihydro-pyrido2,3-dpyrimidin-2-yl-ethyl}-N-pyridin-3-yl-methyl-2-(4-trifluoromethoxy-phenyl)-acetamide (AMG 487) in Human Subjects After Multiple Dosing

Tonn, George R.; Wong, Simon G.; Wong, Sylvia C.; Johnson, Michael G.; Ma, Ji; Cho, Robert; Floren, Leslie C.; Kersey, Kathryn; Berry, Karen; Marcus, Andrew P.; Wang, Xuemei; Van Lengerich, Bettina; Medina, Julio C.; Pearson, Paul G.; Wong, Bradley K.

Follow Drug Metabolism and Disposition , Volume 37 (3): 502 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

Decreased Susceptibility of the Cytochrome P450 2B6 Variant K262R to Inhibition by Several Clinically Important Drugs

Talakad, Jyothi C.; Kumar, Santosh; Halpert, James R.

Follow Drug Metabolism and Disposition , Volume 37 (3): 644 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

SIMDOT-AbMe: Microphysiologically Based Simulation Tool for Quantitative Prediction of Systemic and Local Bioavailability of Targeted Oral Delivery Formulations

Haddish-Berhane, Nahor; Farhadi, Ashkan; Nyquist, Chell; Haghighi, Kamyar; Keshavarzian, Ali

Follow Drug Metabolism and Disposition , Volume 37 (3): 608 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

Absorption, Metabolism, and Excretion of 14CVildagliptin, a Novel Dipeptidyl Peptidase 4 Inhibitor, in Humans

He, Handan; Tran, Phi; Yin, Hequn; Smith, Harold; Batard, Yannick; Wang, Lai; Einolf, Heidi; Gu, Helen; Mangold, James B.; Fischer, Volker; Howard, Dan

Follow Drug Metabolism and Disposition , Volume 37 (3): 536 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

Carrier-Mediated Uptake of 1-(2-Methoxyethyl)-2-methyl-4,9-dioxo-3-(pyrazin-2-ylmethyl)-4,9-dihydro-1H-naphtho2,3-dimidazolium Bromide (YM155 Monobromide), a Novel Small-Molecule Survivin Suppressant, into Human Solid Tumor and Lymphoma Cells

Minematsu, Tsuyoshi; Iwai, Megumi; Sugimoto, Kenji; Shirai, Nobuaki; Nakahara, Takahito; Usui, Takashi; Kamimura, Hidetaka

Follow Drug Metabolism and Disposition , Volume 37 (3): 619 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

Advanced Filters:

Specific Data Sources:

Drug Metabolism and Disposition Volume 37 Issue 3

1 - 10 of 31 articles

Schlicht, Kari E.; Berg, Jeannette Zinggeler; Murphy, Sharon E.

Follow Drug Metabolism and Disposition , Volume 37 (3): 665 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

Zhang, Jun; Chaluvadi, Madhusudana R.; Reddy, Rob; Motika, Meike S.; Richardson, Terrilyn A.; Cashman, John R.; Morgan, Edward T.

Follow Drug Metabolism and Disposition , Volume 37 (3): 462 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

Abe, Koji; Bridges, Arlene S.; Brouwer, Kim L. R.

Follow Drug Metabolism and Disposition , Volume 37 (3): 447 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

Syvänen, Stina; Lindhe, Örjan; Palner, Mikael; Kornum, Birgitte R.; Rahman, Obaidur; Långström, Bengt; Knudsen, Gitte M.; Hammarlund-Udenaes, Margareta

Follow Drug Metabolism and Disposition , Volume 37 (3): 635 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

Nishiya, Yumi; Hagihara, Katsunobu; Ito, Takashi; Tajima, Masami; Miura, Shin-ichi; Kurihara, Atsushi; Farid, Nagy A.; Ikeda, Toshihiko

Follow Drug Metabolism and Disposition , Volume 37 (3): 589 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

Tonn, George R.; Wong, Simon G.; Wong, Sylvia C.; Johnson, Michael G.; Ma, Ji; Cho, Robert; Floren, Leslie C.; Kersey, Kathryn; Berry, Karen; Marcus, Andrew P.; Wang, Xuemei; Van Lengerich, Bettina; Medina, Julio C.; Pearson, Paul G.; Wong, Bradley K.

Follow Drug Metabolism and Disposition , Volume 37 (3): 502 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

Talakad, Jyothi C.; Kumar, Santosh; Halpert, James R.

Follow Drug Metabolism and Disposition , Volume 37 (3): 644 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

Haddish-Berhane, Nahor; Farhadi, Ashkan; Nyquist, Chell; Haghighi, Kamyar; Keshavarzian, Ali

Follow Drug Metabolism and Disposition , Volume 37 (3): 608 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

He, Handan; Tran, Phi; Yin, Hequn; Smith, Harold; Batard, Yannick; Wang, Lai; Einolf, Heidi; Gu, Helen; Mangold, James B.; Fischer, Volker; Howard, Dan

Follow Drug Metabolism and Disposition , Volume 37 (3): 536 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009

Minematsu, Tsuyoshi; Iwai, Megumi; Sugimoto, Kenji; Shirai, Nobuaki; Nakahara, Takahito; Usui, Takashi; Kamimura, Hidetaka

Follow Drug Metabolism and Disposition , Volume 37 (3): 619 Am. Soc for Pharma & Experimental Therapeutics – Mar 1, 2009